Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Int J Gynecol Cancer. 2012 Oct;22(8):S45-57. doi: 10.1097/IGC.0b013e31826bd1f2.
To review the current understanding of the underlying molecular, biologic, and genetic mechanisms involved in ovarian cancer development and how these mechanisms can be targets for prevention, detection, and treatment of the disease and its recurrence.
In May 2012, we convened a meeting of researchers, clinicians, and consumer advocates to review the state of current knowledge on molecular mechanisms and identify fruitful areas for further investigations.
The meeting consisted of 7 scientific sessions ranging from Epidemiology, Early Detection, and Biology to Therapeutics and Quality of Life. Sessions consisted of talks and panel discussions by international leaders in ovarian cancer research. A special career development session by the Congressionally Directed Medical Research Program Department of Defense Ovarian Cancer Academy as well as an oral abstract and poster session showcased promising new research by junior scientists.
Technological advances in the last decade have increased our knowledge of the molecular mechanisms involved in a host of biological activities related to ovarian cancer. Understanding the role these mechanisms play in cancer initiation and progression will help lead to the development of prevention and treatment modalities that can be personalized to each patient, thereby helping to overcome this highly fatal malignancy.
综述卵巢癌发生过程中涉及的潜在分子、生物学和遗传学机制的现有认识,以及这些机制如何成为疾病及其复发的预防、检测和治疗的靶点。
2012 年 5 月,我们召集了研究人员、临床医生和消费者权益倡导者举行会议,以审查有关分子机制的现有知识状况,并确定进一步研究的有成果领域。
会议由流行病学、早期检测和生物学、治疗学和生活质量共 7 个科学会议组成。会议由卵巢癌研究领域的国际领导者进行演讲和小组讨论。国会定向医学研究计划国防部卵巢癌学院的特别职业发展会议以及口头摘要和海报会议展示了初级研究人员有前途的新研究。
过去十年中技术的进步增加了我们对与卵巢癌相关的一系列生物学活动中涉及的分子机制的认识。了解这些机制在癌症发生和进展中的作用将有助于开发能够针对每个患者进行个性化的预防和治疗方法,从而有助于克服这种高度致命的恶性肿瘤。